---
figid: PMC6366304__JCO.2014.59.0018f2
figlink: /pmc/articles/PMC6366304/figure/F2/
number: Fig 2
caption: Common nodes of resistance to targeted therapies within the PI3K pathway.
  PI3K pathway alterations that confer resistance to targeted therapies across various
  tumor types are shown. CRC, colorectal cancer; EGFR, epidermal growth factor receptor;
  HER2, human epidermal growth factor receptor 2; HR, hormone receptor; INPP4B, inositol
  polyphosphate 4-phosphatase type II; MET, hepatocyte growth factor receptor; mTORC,
  mammalian target of rapamycin complex; PDK1, phosphoinositide-dependent kinase 1;
  PI3K, phosphoinositide 3-kinase; PIK3CA, phosphatidylinositol 3-kinase catalytic
  subunit alpha; PIK3CG, phosphatidylinositol 3-kinase catalytic subunit gamma; PIK3R2,
  phosphatidylinositol 3-kinase regulatory subunit beta; PIP2, phosphatidylinositol
  4,5- bisphosphate; PIP3, phosphatidylinositol 3,4,5-trisphosphate; PTEN, phosphatase
  and tensin homolog; RTK, receptor tyrosine kinase.
pmcid: PMC6366304
papertitle: Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors.
reftext: Patricia Mucci LoRusso. J Clin Oncol. 2016 Nov 1;34(31):3803-3815.
pmc_ranked_result_index: '17965'
pathway_score: 0.8599766
filename: JCO.2014.59.0018f2.jpg
figtitle: Common nodes of resistance to targeted therapies within the PI3K pathway
year: '2016'
organisms: Homo sapiens
ndex: 9f81e673-dea2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6366304__JCO.2014.59.0018f2.html
  '@type': Dataset
  description: Common nodes of resistance to targeted therapies within the PI3K pathway.
    PI3K pathway alterations that confer resistance to targeted therapies across various
    tumor types are shown. CRC, colorectal cancer; EGFR, epidermal growth factor receptor;
    HER2, human epidermal growth factor receptor 2; HR, hormone receptor; INPP4B,
    inositol polyphosphate 4-phosphatase type II; MET, hepatocyte growth factor receptor;
    mTORC, mammalian target of rapamycin complex; PDK1, phosphoinositide-dependent
    kinase 1; PI3K, phosphoinositide 3-kinase; PIK3CA, phosphatidylinositol 3-kinase
    catalytic subunit alpha; PIK3CG, phosphatidylinositol 3-kinase catalytic subunit
    gamma; PIK3R2, phosphatidylinositol 3-kinase regulatory subunit beta; PIP2, phosphatidylinositol
    4,5- bisphosphate; PIP3, phosphatidylinositol 3,4,5-trisphosphate; PTEN, phosphatase
    and tensin homolog; RTK, receptor tyrosine kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R6
  - PIK3CB
  - AKT3
  - AKT1
  - PDK1
  - PIK3R5
  - AKT2
  - SART3
  - EGFR
  - BRAF
  - MAP2K2
  - MET
  - MTOR
  - MAP2K1
  - HRAS
  - KRAS
  - NRAS
  - RPTOR
  - INPP4B
  - PIK3R4
  - PIK3CA
  - PIK3R2
  - PIK3CG
  - PIK3R3
  - PTEN
  - PIK3CD
  - estrogen
  - Cancer
  - Lung cancer
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: AKT1/3
  symbol: AKT1
  source: hgnc_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT1/3
  symbol: AKT3
  source: hgnc_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: (RAS-mutant
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: (RAS-mutant
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: (RAS-mutant
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: INPP4B
  symbol: INPP4B
  source: hgnc_symbol
  hgnc_symbol: INPP4B
  entrez: '8821'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PIK3CA
  symbol: PIK3CA
  source: hgnc_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PIK3R2
  symbol: PIK3R2
  source: hgnc_symbol
  hgnc_symbol: PIK3R2
  entrez: '5296'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
chemicals:
- word: estrogen
  source: MESH
  identifier: D004967
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
